Načítá se...
Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
Key cytotoxic drugs of chemotherapy for gastroesophageal cancer include fluoropyrimidine, platinum, taxanes and irinotecan. Concurrent chemoradiotherapy is one of the main treatment strategies, especially for esophageal cancer. As molecular target agents, the anti-HER2 antibody trastuzumab for HER2-...
Uloženo v:
| Vydáno v: | World J Gastrointest Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657220/ https://ncbi.nlm.nih.gov/pubmed/31367271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v11.i7.518 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|